Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc., CEO Roger Crystal, M.D., to Present to President's Commission on Combating Drug Addiction and the Opioid Crisis

SANTA MONICA, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc., (“Opiant”) (NASDAQ:OPNT), today announced that Chief Executive Officer Roger Crystal, M.D., has been invited to...
September 15, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Provides an Update on NARCAN® Nasal Spray

SANTA MONICA, Calif., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
September 06, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

SANTA MONICA, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
September 05, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Announces Appointment of David O’Toole as Chief Financial Officer

SANTA MONICA, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for...
August 28, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Announces Listing on the Nasdaq Capital Market

SANTA MONICA, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions,...
August 14, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant CEO Roger Crystal Appears on Fox News Channel to Discuss the Opioid Crisis Being Declared a National Emergency

SANTA MONICA, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions,...
August 10, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

SANTA MONICA, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions,...
August 04, 2017 07:00 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN® Nasal Spray Patent

SANTA MONICA, Calif., Aug. 04, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions...
July 27, 2017 08:44 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant CEO Roger Crystal Appears on Fox & Friends

SANTA MONICA, Calif., July 27, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions...
July 26, 2017 13:14 ET | Source: Opiant Pharmaceuticals, Inc.

Opiant CEO Roger Crystal Appears on Fox Business Network

SANTA MONICA, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions...